Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06108830 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients

StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 4, 2024 (before its estimated November 30, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Primary completion date: May 31, 2024 to Nov 30, 2024
    • Study completion date: Jun 10, 2024 to Dec 10, 2024
    v4
  3. Primary completion date: Jan 31, 2024 to May 31, 2024
    • Study completion date: Feb 10, 2024 to Jun 10, 2024
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To explore the effects of esketamine combined with remimazolam on postoperative sleep disturbance and anxiety in surgical patients undergoing gastroenteroscopies
Trial Details
NCT Number NCT06108830
Lead Sponsor Tianjin Medical University General Hospital
Conditions
(from sponsor)		 Sleep Disturbance
Related terms Anxiety Disorders, Parasomnias
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov